Calpain-1 inhibitor prevent loss of dystrophin in experimental se | 51463
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Calpain-1 inhibitor prevent loss of dystrophin in experimental septic cardiomyopathy induced by cecal ligation and puncture (CLP)

4th International Conference on Clinical & Experimental Cardiology

April 14-16, 2014 Hilton San Antonio Airport, TX, USA

Ana C.S. Freitas, Maria Jos� Figueiredo, Patricia Ferezin , Erica C Campos , Marcos A Rossi and Mara Rubia N Celes

Accepted Abstracts: J Clin Exp Cardiolog

Abstract :

Evidences from our laboratory demonstrated that cytosolic calcium overload caused increase activation of intracellular calcium-dependent proteases, such as calpain-1 resulting in sarcolemal dystrophin disruption in severe sepsis induced by CLP in mice. This study was designed to determine the hypothesis that N-Acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN), calpain-1 inhibitor, could attenuate dystrophin disruption and cardiac contractile proteins loss/reduction in experimental sepsis induced by CLP. Male C57Bl/6 mice were subjected to sham and severe septic injury (SSI) induced by CLP. Half of animals from each group were treated with ALLN (3mg/kg, SSI+ALLN; SH+ALLN) 4hs after surgery. In SSI+ALLN mice reduced amounts of myocardial calpain-1 were associated with increased actin/myosin expression as compared to SSI mice. Additionally, ALLN treatment of septic mice significantly prevented loss of dystrophin and β-dystroglycan as compared to SSI mice. Concurrently, SSI+ALLN mice presented an increased survival rate. Calpain inhibitor, ALLN, suppressed the increased calpain-1 expression and prevented myocardial structural injury caused by experimental severe sepsis. These observations reinforce the concept that calpain-1 activation represents a key target in dystrophin disruption behind cardiac dysfunction in severe sepsis/septic shock. Further studies are needed to elucidate this mechanism that may provide new interventional pathways to prevent septic cardiomyopathy.